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Background: The Institute of Medicine has prioritized shared decision making (SDM), yet little is known about the
impact of SDM over time on behavioral outcomes for children. This study examined the longitudinal association of
SDM with behavioral impairment among children with special health care needs (CSHCN).
Method: CSHCN aged 5-17 years in the 2002-2006 Medical Expenditure Panel Survey were followed for 2 years. The
validated Columbia Impairment Scale measured impairment. SDM was measured with 7 items addressing the 4
components of SDM. The main exposures were (1) the mean level of SDM across the 2 study years and (2) the
change in SDM over the 2 years. Using linear regression, we measured the association of SDM and behavioral
impairment.
Results: Among 2,454 subjects representing 10.2 million CSHCN, SDM increased among 37% of the population,
decreased among 36% and remained unchanged among 27%. For CSHCN impaired at baseline, the change in SDM
was significant with each 1-point increase in SDM over time associated with a 2-point decrease in impairment (95%
CI: 0.5, 3.4), whereas the mean level of SDM was not associated with impairment. In contrast, among those below
the impairment threshold, the mean level of SDM was significant with each one point increase in the mean level of
SDM associated with a 1.1-point decrease in impairment (0.4, 1.7), but the change was not associated with
impairment.
Conclusion: Although the change in SDM may be more important for children with behavioral impairment and
the mean level over time for those below the impairment threshold, results suggest that both the change in SDM
and the mean level may impact behavioral health for CSHCN.
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Shared decision making (SDM) is defined as the active
participation of both clinicians and families in treatment
decisions, the exchange of information, discussion of
preferences, and a joint determination of the treatment
plan [1]. Given benefits of SDM in increasing families’* Correspondence: fiks@email.chop.edu
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reproduction in any medium, provided the orknowledge, decreasing uncertainty, and pairing families
with treatments they find most acceptable [2], the Insti-
tute of Medicine (IOM) recently stressed the importance
of research assessing the comparative effectiveness of
SDM in pediatrics [3] and the 2010 Patient Protection
and Affordable Care Act supported the implementation
of SDM in clinical settings [4]. Despite the prioritization
of research on SDM, little work has investigated the as-
sociation of SDM with children’s health.
SDM is particularly useful when families must balance
the risks and benefits of more than one evidence-based
treatment. This process therefore may be especially help-
ful in the management of behavioral problems since. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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treatments, often informed by strongly held personal
and cultural values. Concerns such as cost, accessibility,
stigma, effectiveness, and side effects have been shown
to shape these decisions [5]. By addressing families’ pre-
ferences, SDM explicitly incorporates values into the de-
cision making process. As a result, beliefs that could
undermine treatment acceptability, engagement and ad-
herence may be discussed prior to the selection of thera-
peutic options and potentially lead to a better match
between families and treatments.
Children with special health care needs (CSHCN),
those who have or are at increased risk of a chronic
physical, developmental, behavioral, or emotional condi-
tion and who require health and related services beyond
that required by children generally [6], are an ideal
population for the study of the impact of SDM on be-
havioral health. Approximately 10 to 12 million United
States (US) children have special health care needs [7],
up to 30% of CSHCN have a behavioral or emotional
disorder [8,9], and behavior problems are often more se-
vere among CSHCN than others [10,11]. Furthermore,
even for children without a diagnosed behavioral or
mental health condition, the presence of a special health
care need often increases the need for mental health ser-
vices for both affected children and their families [9].
To address these often multi-faceted problems, collab-
oration between clinicians and families has become a
priority for these children. Ensuring “that families part-
ner in decision making at all levels and are satisfied with
the services they receive” is one of the Maternal and
Child Health Bureau’s 6 core outcomes for CSHCN [12].
Still, little attention has focused specifically on the asso-
ciation of SDM with children’s behavioral health and
how patterns of SDM over time may impact behavioral
outcomes. To address this knowledge gap and provide
guidance for pediatric clinicians who routinely treat be-
havioral problems, we conducted a longitudinal study of
SDM and behavioral health among a national sample of
US CSHCN. We hypothesized that both higher mean
levels of SDM over time as well as increasing SDM
would be associated with improved behavioral health.
Methods
Study design and data source
We conducted a longitudinal analysis of the Medical Ex-
penditure Panel Survey (MEPS), administered annually
by the Agency for Healthcare Research and Quality
(AHRQ) and previously used to study CSHCN [13,14].
Between 12,810 and 14,828 households were sampled
annually from the US population, and all children were
followed for 2 years [15]. In MEPS, the person from each
household who was most knowledgeable about the
health of its members provided information on healthstatus, insurance, and utilization. Interviews were sup-
plemented by surveys from medical providers, health
insurers, and employers.
Study sample
The study sample included all children ≥5 and ≤17 years
in MEPS panels 7 to 10 (2002- 2006). Younger children
were excluded because behavioral impairment is not
assessed in MEPS. From this sample, CSHCN were iden-
tified using the validated CSHCN Screener [16,17]. Chil-
dren were excluded if they had no usual source of care
(SDM does not apply in this context), their household
did not respond to any of the items used to create the
SDM measure, or they lacked a value for impairment.
Response rates for completion of all survey rounds for
the years considered ranged from 58.3% to 64.7% [15].
We were able to generalize results to the US population
of CSHCN by applying sampling weights that reflect the
number of people in the US represented by each
respondent.
Outcome measure
The primary outcome was behavioral impairment in the
domains of interpersonal relationships, psychopathology,
functioning at school, and use of leisure time as assessed
during each of the 2 study years by the validated, parent-
reported, 13-item Columbia Impairment Scale (CIS),
which has previously been used with CSHCN [18,19].
Each item is scaled from 0 (no problem) to 4 (a very big
problem) and total scores ≥15 indicate impairment. Even
small differences in mean score may be clinically mean-
ingful. Differences between 1 and 3 points have been
found between groups of children with and without
physical abuse [20] and with and without major depres-
sion [21].
Independent variables
SDM was the primary independent variable. We deter-
mined families’ participation in SDM during each study
year by calculating the mean item score of responses to
7 separate MEPS items that address distinct aspects of
SDM. These items correspond to the four components
of SDM in the most widely accepted definition (Table 1)
[1]. After excluding children without a response to any
of the 7 SDM items, for each item, 7-15% of remaining
children lacked a response. Multiple imputation with 10
data sets was then used to address missing data on these
items in a manner designed to avoid bias and produce
correct confidence intervals [22]. In order to examine
the impact of both the mean level of SDM over the 2
study years and the change in SDM from year 1 to year
2 on behavioral impairment, we considered 2 aspects of
SDM in the analysis. First, we calculated the mean SDM
for each subject across the 2 study years ((year 1 mean
Table 1 Items Included in the Shared Decision Making Score
Shared Decision Making Items from the
Medical Expenditure Panel Survey
Corresponding Component(s) of
the Definition of Shared
Decision Making (See Below).
Unweighted distribution of scores (n, %)1
1 (Never) 2 (Sometimes) 3 (Usually) 4 (Always)
If there were a choice between treatments,
how often would your medical provider ask
you to help make the decision?
1, 4 186 (8%) 277 (11%) 591 (24%) 1400 (57%)
Thinking about the types of medical, traditional
and alternative treatments you are happy with,
how often does your medical provider show
respect for these treatments?
3 62 (3%) 191 (8%) 584 (24%) 1617 (65%)
In the last 12 months, how often did your child’s
doctors or other health providers listen carefully
to you?
2,3 19 (1%) 143 (6%) 541 (22%) 1751 (71%)
In the last 12 months, how often did your child’s
doctors or other health providers explain things
in a way that you could understand?
2, 3 19 (1%) 125 (5%) 460 (19%) 1850 (75%)
In the last 12 months, how often did your child’s
doctors or other health providers show respect for
what you had to say?
3,4 20 (1%) 124 (5%) 477 (19%) 1833 (75%)
In the last 12 months, how often did your child’s
doctors or other health providers spend enough
time with you?
2 53 (2%) 166 (7%) 559 (23%) 1676 (68%)
1 (No) 4 (Yes)
Does a medical person at your usual source of
care present and explain all options to you?
2 144 (6%) 2310 (94%)
Components of Shared Decision Making
(1) Both the doctor and the patient are involved in the
treatment decision-making process;
(2) Both share information with each other;
(3) Both take steps to participate in the decision-making process
by expressing treatment preferences;
(4) Both the doctor and the patient ree on the treatment
to implement
1Missing data (7-15% for each item) was imputed using multiple imputation.
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change in SDM, a pattern of increasing, decreasing, or
unchanged SDM, we calculated the difference between
each subject’s SDM score in each year and their mean
SDM score over the 2 study years. This approach effect-
ively partitioned the change across the 2 study years and
centered all of the change at zero, allowing a longitu-
dinal analysis to be conducted as was appropriate for the
data structure.
Covariates and effect modification
We considered as covariates clinical and demographic
variables that might impact the relationship between
SDM and behavioral impairment (Table 2). These
covariates consisted of demographic characteristics in-
cluding the child’s age (5-12 versus 13-17 years), gen-
der, race (White, Black, other) and Hispanic ethnicity,
region of residence (Northeast, Midwest, South,
West), parental education (no high school diploma,high school diploma, bachelor’s degree, graduate level
degree, or other degree), and household income (poor
(<100% of the applicable poverty line), near poor (100
to <125%), low (125 to <200%), middle (200 to <400%),
high (≥400%)) as well as any private health insurance
(versus other insurance or none). To ensure that find-
ings were not confounded by child health, we adjusted
for general health status based on the overall score
(low (<15), medium (15 to <20), and high (≥20)) from 5
Likert-scaled items derived from the parent-reported
Child Health Questionnaire, General Health Subscale
[23]. Specifically, we controlled for whether health sta-
tus improved, remained unchanged, or declined be-
tween years 1 and 2 of the study. To control for the
impact of specific behavioral treatments, we also
adjusted for whether children received any psycho-
tropic medications (includes stimulants, antidepres-
sants, antipsychotics, anticonvulsants, as well as other
psychotropic medications such as alpha agonists) or
Table 2 Comparing Characteristics of Children with
Special Health Care Needs (CSHCN), Age 5-17 Years, by
Shared Decision Making Pattern1















5-12 70.0 64.1 0.2
13-17 30.0 35.9
Female 44.0 44.3 0.9
Race
White 78.4 69.6 0.009
Black 16.1 18.5
Other 5.5 11.9
Hispanic 12.5 16.9 0.1
Region





No Degree 10.3 17.8 0.1
High School Complete 46.4 48.2
Bachelor's Degree 16.7 12.8
Graduate Level Degree 11.9 11.6
Other Degree 14.7 9.6
Poverty
Poor 18.4 22.2 0.007
Near Poor 5.9 8.9
Low Income 15.0 24.9
Middle Income 31.5 27.5
High Income 29.2 16.5
Insurance Coverage
Any private 65.4 52.9 0.01
Other 34.6 47.1
Clinical Characteristics % %
General Health Status3
Increasing 20.4 20.1 0.9
Unchanged 59.8 60.4
Decreasing 19.8 19.5
Diagnosed with ADHD 19.8 8.3 0.001
Table 2 Comparing Characteristics of Children with
Special Health Care Needs (CSHCN), Age 5-17 Years, by
Shared Decision Making Pattern1 (Continued)




Diagnosed with Asthma 20.1 19.3 0.8
Any psychotropic
medication use4
None 70.7 85.6 0.01
Year 1 only 2.9 2.8
Year 2 only 6.1 3.9
Both years 20.3 6.7
Any mental health services use5
None 76.5 68.8 <0.001
Year 1 only 6.1 20.1
Year 2 only 6.8 5.8
Both years 10.6 5.3
1Children excluded from the study lacked a usual source of care, had no
response to any of the items used to create the SDM measure, or lacked a
response to items from the Columbia Impairment Scale used to assess
behavioral impairment.
2 P values calculated by chi-square tests with robust variance estimates
accounting for the weighted, clustered, and stratified longitudinal MEPS
survey design.
3General Health Status determined using the overall score from 5 Likert-scaled
items (recoded so that a score of 5 indicates the best health and a score of 1
the worst health) derived from the Child Health Questionnaire, General Health
Subscale (child seems less healthy than other children, child has never been
seriously ill, child usually catches whatever is going around, expect child will
have a healthy life, respondent worries more than is usual about child’s
health). For each year, the overall score was categorized as (low (<15),
medium (15 to <20), or high (≥20)).
4 Psychotropic medications considered included stimulants, antidepressants,
antipsychotics, anticonvulsants, as well as other psychotropic medications
such as alpha agonists.
5 Mental health services include visits to a psychiatrist, psychologist, or other
mental health professional.
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psychologist, or other mental health professional) in
only the first year, only the second year, both study
years or never.
Because our initial analyses demonstrated that the as-
sociation of SDM with behavioral impairment differed
with the baseline level of impairment, we evaluated our
primary outcome separately in CSHCN who were
impaired at baseline and in those who were unimpaired.
Although the study sample size was too small to test effect
modification formally based on diagnosis or treatment re-
ceipt, we conducted separate secondary analyses including
clinically relevant subpopulations: children diagnosed with
asthma, children with attention-deficit/hyperactivity dis-
order (ADHD), those taking psychotropic medication, and
those utilizing mental health services.
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Characteristics of the study sample
We initially described the weighted proportion of
CSHCN in MEPS included versus excluded from the
study and compared the characteristics of CSHCN
with each pattern of SDM using chi-square tests. We
then plotted each subject’s SDM score in year 1 versus
year 2 to observe differences over time, and calculated
Pearson correlation coefficients and p-values. Following
guidance from AHRQ, all statistical analyses accounted
for the weighted, clustered, and stratified MEPS survey
design, an approach that provides conservative esti-
mates that account for repeated measures over time
[24]. In all analyses, P values of <0.05 were considered
significant.Assessing the impact of SDM on behavioral impairment
To assess the association between SDM and CIS score
over time, linear models with robust variance estimates
that reflect the complex survey design were created
with the change in CIS score as the outcome and with
the mean level of SDM score across the two years as
well as the change in SDM as the 2 independent vari-
ables. The use of robust variance estimates as well as
change scores limited the impact of the skewed distri-
bution of SDM on confidence bounds and significance
levels in our analyses. These models were developed
separately for CSHCN who were impaired at baseline
and those who were unimpaired. In each analysis, we
constructed models with and without covariates. Since
the inclusion of covariates did not alter the association
of SDM with behavioral health, covariates were
dropped from the final models presented in the
Results section. Analyses used Stata 10 and 11 (College
Station, Texas). The CHOP Institutional Review Board
determined this study, which involved only de-
identified, publically available data, to be exempt from
IRB oversight.Figure 1 Shared decision making scores in year 1 and year 2:
overall high correlation of scores (r = 0.8, p < .001), with
substantial individual variability. Fitted line reflects the correlation
between year 1 and year 2.Results
Study sample
Based on the survey methodology, the study sample of
2,454 represented a population of 10.2 million US
CSHCN. This sample included 94% of the weighted
population of US CSHCN (Table 2). Compared to
included children those excluded were significantly more
likely to be of Black or other race, to be from the South,
to have higher levels of poverty, and no private health
insurance. Excluded children were also less likely to be
diagnosed with ADHD, less likely to be taking psycho-
tropic medication, and less likely to be utilizing mental
health services in both years.Extent of behavioral impairment and patterns of shared
decision making
At baseline, the mean CIS score among all CSHCN was
10.6 out of 52 and 34.2% of CSHCN had impaired be-
havior (score ≥15 represents impairment). Baseline CIS
scores were higher among children diagnosed with
ADHD (15.9 versus 9.3, p < 0.001) and lower among
those with asthma (8.9 versus 11.0, p < 0.001) compared
to other CSHCN. Similarly, CIS scores were higher for
those on psychotropic medication versus none (16.7 ver-
sus 8.7, p < .001) and receiving mental health services
versus none (18.0 versus 9.1, p < .0001).
At baseline, the mean SDM score among all CSHCN
was 3.6 out of 4. The distribution of responses to the
SDM items is shown in Table 1. Figure 1 plots the mean
SDM score for each subject in year 2 by the mean score
in year 1. While the SDM score in year 1 was strongly
associated with SDM score in year 2 (r = 0.7, p < 0.001),
37% of families reported an increase in SDM, 36%
reported a decrease, and only 27% remained unchanged.
Among those whose SDM score increased, 88%
increased by <1.0 (out of 4.0 possible), 11% increased by
1.0 to <2.0, and 1% increased ≥2.0. Among those whose
SDM score decreased, 90% decreased by <1.0, 9%
decreased by 1.0 to <2.0, and 1% decreased by ≥2.0.
Association of shared decision making with behavioral
impairment
The impact of SDM on behavioral impairment differed
among CSHCN who were impaired versus unimpaired
at baseline (Figure 2). Among CSHCN who were not
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points (0.4, 1.7) with each one point increase in the
mean level of SDM (Figure 2A). In this group, the
change in SDM over time was not significantly asso-
ciated with impairment (Figure 2B). In contrast, for
CSHCN impaired at baseline, the change in SDM was
significant with each 1-point increase in SDM over time
associated with a 2-point decrease in impairment (95%
CI: 0.5, 3.4). However, the mean level of SDM was not
significantly associated with impairment.
In secondary analyses of subgroups of CSHCN, results
were only significant for those receiving mental health
services, the subgroup with the highest impairment
(Figure 2). Consistent with our main results, the change
in SDM, but not the mean level of SDM, was significant
with each 1-point increase in SDM over time associated
with decreases in impairment of 2.3 points (95% CI: 0.1,
4.6). Trends were similar for other subgroups.
Discussion
In this study, the first national, longitudinal research pro-
ject examining the association of SDM with behavioralFigure 2 Different groups of CSHCN are affected more by either the m
decrease in impairment associated with each 1-point increase in the mean
with each 1-point increase in SDM over time, a measure of the change in Simpairment in children, we hypothesized that both
higher sustained levels and increasing patterns of SDM
would be associated with decreased impairment among
CSHCN. While consistent with our hypothesis, study
results showed different patterns of SDM may be most
beneficial for children with versus without high levels of
impairment at baseline. We found that higher mean
levels of SDM were associated with improvements
among children below the threshold for behavioral im-
pairment, but only an increase in SDM was associated
with significantly improved behavioral health among
those with impairment. Although prospective study is
warranted to more thoroughly detail how SDM impacts
behavioral health, these novel results suggest that
increases in SDM may be needed to achieve the best out-
comes for children with behavioral impairment, while
sustained SDM over time may be more effective to help
CSHCN with behavior problems that adversely affect
families but fall below the impairment threshold.
A possible explanation for these findings may be the dis-
tinct types of decisions that pediatric clinicians and families
share when children have varying levels of impairment.ean level of SDM or by an increase in SDM. Plot A shows the
level of SDM. Plot B shows the decrease in impairment associated
DM.
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focus on starting new medical or behavioral treatments that
may result in substantial improvements in behavior. In-
creasing SDM in this context may maximize the likelihood
that these treatments are optimized with input from the
family in order to best limit impairment. Sustained SDM,
as reflected in the mean, might be less important in this
context than increasing SDM specifically when major
decisions are reached. In contrast, when behavior pro-
blems fall below the impairment threshold, clinicians may
instead focus on incremental interventions that make
many small improvements over time. In this context, sus-
tained SDM in which families and clinicians jointly ad-
dress minor difficulties over a period of more than one
year may help reduce impairment. Since our findings are
novel, further study is needed to better understand and
confirm these relationships.
While not directly addressing SDM, the few pediatric
interventions designed to improve behavioral health by
either fostering communication or the medical home, a
broader term including care coordination as well as
SDM, have had mixed results. A trial of communication
skills training for urban pediatric clinicians led by a
psychiatrist and drawing from techniques of family-
centered care, family and cognitive behavioral therapy,
and family engagement, decreased parent-rated impair-
ment among minority, but not white children with be-
havior problems [25]. A study of the 2007 National
Survey for Children’s Health found that children with
ADHD cared for in a medical home were less likely to
have difficulties participating in activities or making
friends [26]. In a rural area, a program to enhance com-
prehensive, coordinated care for CSHCN with nurse
practitioner home visits, goal setting, and follow-up
resulted in improved functioning for the family, but not
the child [27].
In the context of mixed findings from these interven-
tions, the benefits of SDM in our results justify prospect-
ive study examining the impact of interventions to foster
SDM on childhood behavioral health. Extensive research
primarily targeting adults has been devoted to develop-
ing decision aids, standardized and validated tools spe-
cifically created to foster SDM by helping families
consider the risks and benefits of specific treatments in
the context of their personal values [2]. Decision aid use
results in improved decision making, but not consist-
ently improved health outcomes [2]. Unlike decision aids
which focus on optimizing individual decisions, the
items used in this study assess SDM in the broader con-
text of care which may explain the difference in our
findings. Since prior research indicates that improved
communication between families at home and their
pediatricians is strongly associated with SDM [28] but
that SDM occurs inconsistently in clinical encounterswith impaired children [29], two types of interventions
may be needed: decisions aids to foster SDM within
encounters and office-based systems such as expanded
telephone hours or patient portals to foster ongoing col-
laboration and SDM. Office-based staff may also provide
outreach to enhance the ongoing shared decision mak-
ing process.
The longitudinal design of this study allowed us to in-
vestigate how patterns of SDM change over time, an
area that has received little attention in prior research.
We found that 36% of households reported increasing,
37% decreasing, and 27% unchanged SDM. Among pos-
sible explanations for these shifts, SDM may increase as
families gain experience with different treatment modal-
ities and are better able to participate or may increase or
decrease when families switch clinicians and a new part-
nership develops. Child health status as well as families’
outlook and level of stress, factors known to influence
pediatric palliative care decision making [30], may also
impact families’ and clinicians’ willingness and ability to
participate in SDM.
While this study is the first to use a nationally repre-
sentative sample to assess the impact of SDM on chil-
dren’s behavioral health over time, it has several
limitations. Although we considered 7 items with face
validity based on their correspondence with the defin-
ition of SDM [1], additional items might have allowed us
to further refine our measure and better assess variabil-
ity in SDM. SDM has been conceptualized as existing
between the extremes of paternalistic decision making
by the doctor alone and informed decision making by
the patient or family alone [1]. However, our study
measure limited us to assessing only extent of family in-
volvement in decision making, not who ultimately made
decisions. In addition, we relied on household report as
opposed to direct observation of SDM. We could not
verify how options were presented. Families also might
have been more likely to report increased SDM when
their children became less impaired, an association
that might have biased our results. Although we
adjusted for child health status, a similar construct to
impairment, and found no impact on results, this
might not have fully accounted for the impact of im-
pairment on reported SDM. Furthermore, while our
data set provided a national perspective, we conducted
an observational study that used a single measure of
behavioral health. Trials are needed to definitively as-
sess how SDM impacts behavior using multiple mea-
sures of the process and outcomes. Given limits in our
sample size that prevented formal tests of effect modi-
fication, these studies should also distinguish the im-
pact of SDM in the general population of CSHCN
versus among those with primarily behavioral or phys-
ical conditions.
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We found that SDM was associated with improved
behavioral health for US CSHCN. However, different
patterns of SDM were associated with improved be-
havioral health for children with higher versus lower
levels of impairment. These results suggest that in-
creasing SDM may be needed to achieve the best out-
comes for children with the greatest behavioral
impairment, while sustained SDM over time may be
more effective to help CSHCN with behavior pro-
blems that fall below the impairment threshold. Pro-
spective research is needed to evaluate the impact of
strategies to both augment and sustain SDM for this
population.
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